Quarterly report · Q1
6960.TEDINET S100OV56
Period2022-04-01 → 2022-06-30
Filed2022-08-05
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥27.7bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥132.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥27.6bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥4.0bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥4.2bn | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥4.4bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥23.4bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.3bn | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥4.4bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥4.3bn | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.9bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥16.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.8bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.9bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥2.8bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥191.7bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥195.5bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥182.0bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥41.9bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥45.6bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥149.8bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥149.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥137.5bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥64.0bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥64.1bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥188.54 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1,072.38 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥183.31 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 78.1% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.5% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q1r_E02304-000Consumables And Other Productsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥7.8bn |
| jpcrp040300-q1r_E02304-000Consumables And Other Productsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥7.8bn |
| jpcrp040300-q1r_E02304-000Consumables And Other Productsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥817m |
| jpcrp040300-q1r_E02304-000Medical Treatment Equipmentreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥12.7bn |
| jpcrp040300-q1r_E02304-000Medical Treatment Equipmentreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥12.7bn |
| jpcrp040300-q1r_E02304-000Medical Treatment Equipmentreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.4bn |
| jpcrp040300-q1r_E02304-000Patient Monitoring Equipmentreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.1bn |
| jpcrp040300-q1r_E02304-000Patient Monitoring Equipmentreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥2.1bn |
| jpcrp040300-q1r_E02304-000Patient Monitoring Equipmentreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥282m |
| jpcrp040300-q1r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥5.1bn |
| jpcrp040300-q1r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥5.1bn |
| jpcrp040300-q1r_E02304-000Physiological Diagnostic Equipmentreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥583m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥27.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥27.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥4.0bn |
| jpcrp040300-q1r_E02304-000Consumables And Other Productsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥7.4bn |
| jpcrp040300-q1r_E02304-000Consumables And Other Productsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥7.4bn |
| jpcrp040300-q1r_E02304-000Consumables And Other Productsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥931m |
| jpcrp040300-q1r_E02304-000Medical Treatment Equipmentreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥12.7bn |
| jpcrp040300-q1r_E02304-000Medical Treatment Equipmentreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥12.7bn |
| jpcrp040300-q1r_E02304-000Medical Treatment Equipmentreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥2.3bn |
| jpcrp040300-q1r_E02304-000Patient Monitoring Equipmentreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥2.6bn |
| jpcrp040300-q1r_E02304-000Patient Monitoring Equipmentreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥2.6bn |
| jpcrp040300-q1r_E02304-000Patient Monitoring Equipmentreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥344m |
| jpcrp040300-q1r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥5.0bn |
| jpcrp040300-q1r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥5.0bn |
| jpcrp040300-q1r_E02304-000Physiological Diagnostic Equipmentreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥597m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-06-30 | ¥27.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-06-30 | ¥27.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-06-30 | ¥4.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 365
| Item | Context | Value | Unit |
|---|---|---|---|
| Interest income noi | Prior1YTDDuration | 17000000 | JPY |
| Interest income noi | CurrentYTDDuration | 16000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 54000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 69000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 6000000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 263000000 | JPY |
| Gain on investments in partnership noi | Prior1YTDDuration | 78000000 | JPY |
| Gain on investments in partnership noi | CurrentYTDDuration | - | JPY |
| Other noi | Prior1YTDDuration | 22000000 | JPY |
| Other noi | CurrentYTDDuration | 43000000 | JPY |
| Non operating income | Prior1YTDDuration | 178000000 | JPY |
| Non operating income | CurrentYTDDuration | 392000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 9000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 8000000 | JPY |
| Loss on investments in partnership noe | Prior1YTDDuration | 42000000 | JPY |
| Loss on investments in partnership noe | CurrentYTDDuration | - | JPY |
| Other noe | Prior1YTDDuration | 5000000 | JPY |
| Other noe | CurrentYTDDuration | 2000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 57000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 11000000 | JPY |
| Ordinary income | Prior1YTDDuration | 4317000000 | JPY |
| Ordinary income | CurrentYTDDuration | 4414000000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 1000000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 4000000 | JPY |
| Gain on sales of investment securities ei | Prior1YTDDuration | 60000000 | JPY |
| Gain on sales of investment securities ei | CurrentYTDDuration | - | JPY |
| Gain on extinguishment of tie in shares ei | Prior1YTDDuration | - | JPY |
| Gain on extinguishment of tie in shares ei | CurrentYTDDuration | 67000000 | JPY |
| Extraordinary income | Prior1YTDDuration | 62000000 | JPY |
| Extraordinary income | CurrentYTDDuration | 72000000 | JPY |
| Loss on sales of noncurrent assets el | Prior1YTDDuration | - | JPY |
| Loss on sales of noncurrent assets el | CurrentYTDDuration | 0 | JPY |
| Impairment loss el | Prior1YTDDuration | 6000000 | JPY |
| Impairment loss el | CurrentYTDDuration | 57000000 | JPY |
| Office transfer expenses el | Prior1YTDDuration | 0 | JPY |
| Office transfer expenses el | CurrentYTDDuration | - | JPY |
| Loss on insurance cancellation el | Prior1YTDDuration | 24000000 | JPY |
| Loss on insurance cancellation el | CurrentYTDDuration | - | JPY |
| Other el | Prior1YTDDuration | - | JPY |
| Other el | CurrentYTDDuration | 0 | JPY |
| Extraordinary loss | Prior1YTDDuration | 31000000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 58000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 4347000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 4428000000 | JPY |
| Income taxes current | Prior1YTDDuration | 1475000000 | JPY |
| Income taxes current | CurrentYTDDuration | 1655000000 | JPY |
| Income taxes deferred | Prior1YTDDuration | 101000000 | JPY |
| Income taxes deferred | CurrentYTDDuration | -78000000 | JPY |
| Income taxes | Prior1YTDDuration | 1576000000 | JPY |
| Income taxes | CurrentYTDDuration | 1576000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |